Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03532256 · ClinicalTrials.gov registry record
Post-op Crowd Sourcing Health Data Via Text-messaging
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 127
- Enrollment target
NCT03532256: Completed study, sponsored by University of Pennsylvania.
NCT03532256 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 127 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03532256 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 127 participants
- Enrollment target
Study Summary
The Center for Disease Control has labeled the opioid prescription drug crisis an "epidemic" in the United States and recently this epidemic has been named a public health emergency. Various medical and surgical societies have begun to release general opioid prescribing guidelines for providers addressing acute pain, but these do not highlight the patient perspective or experience. Identifying an acceptable opioid dose and duration has remained a challenge and is a nuanced process. Though policy and provider driven changes may begin to augment practice, these avenues may miss a crucial perspective; the patient's.
Primary Outcome
We will tally number of pills taken within 28 days for each patient.
Interventions
- BEHAVIORAL Observation
- BEHAVIORAL Text to online survey
- BEHAVIORAL Bi-directional text script
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2019-09-16 |
What the finished NCT03532256 record still lists
NCT03532256 is an observational study that tracks outcomes without assigning an intervention. The registered 127 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Observation is the first listed.
NCT03532256 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03532256 about?
NCT03532256 is a clinical study titled "Post-op Crowd Sourcing Health Data Via Text-messaging". The Center for Disease Control has labeled the opioid prescription drug crisis an "epidemic" in the United States and recently this epidemic has been named a public health emergency. Various medical and surgical societies have begun to release general opioid prescribing guidelines for providers addr...
What is the current status of trial NCT03532256?
This trial is currently completed. The enrollment target is 127 participants. The study started on 2019-07-01. Estimated completion is 2019-09-16.
What interventions are being tested in trial NCT03532256?
The interventions under investigation include: Observation (BEHAVIORAL), Text to online survey (BEHAVIORAL), Bi-directional text script (BEHAVIORAL).
Who is sponsoring clinical trial NCT03532256?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03017820 · 127 participants · Phase 1
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- NCT03609580 · 127 participants · Phase 1
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
- NCT06285643 · 127 participants · Phase 2
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- NCT06809400 · 127 participants · Phase 1
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI